Kommentar zu den Leitlinien (2023) der ESC zum Akuten Koronarsyndrom (ACS)

被引：0

作者：

Wassmann, Sven ^{[1
,2
]}

Gimenez, Maria Rubini ^{[3
]}

Cassese, Salvatore ^{[4
]}

Ghanem, Alexander ^{[5
]}

Schuepke, Stefanie ^{[6
]}

Ong, Peter ^{[7
]}

Schirmer, Stephan Henrik ^{[8
]}

Thiele, Holger ^{[3
]}

Mehilli, Julinda ^{[9
,10
]}

机构：

[1] Herzpraxis Pasing, Munich, Germany

[2] Univ Saarland, Med Fak, Inst Str 14, D-81241 Munich, Germany

[3] Herzzentrum Leipzig, Univ Klin Kardiol, Leipzig, Germany

[4] Deutsch Herzzentrum Munich, Klin Herz & Kreislauferkrankungen, Munich, Germany

[5] Asklepios Klin Nord Heidberg, Innere Med 2, Hamburg, Germany

[6] Privatpraxis Kardiol, Frankfurt Main, Germany

[7] Robert Bosch Krankenhaus, Abt Kardiol & Angiol, Stuttgart, Germany

[8] Kardiopraxis Schirmer, Kaiserslautern, Germany

[9] Krankenhaus Landshut Achdorf, Med Klin 1, Landshut, Germany

[10] Deutsch Gesell Kardiol, Kommiss Klin Kardiovaskulare Med, Dusseldorf, Germany

来源：

KARDIOLOGIE | 2024年 / 18卷 / 06期

关键词：

Secondary prevention; Acute chest pain; Anticoagulation; Antiplatelet therapy; Cardiac revascularisation; ST-SEGMENT ELEVATION; ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; TASK-FORCE; GUIDELINES; CARDIOLOGY; TICAGRELOR; PRASUGREL; OLDER;

D O I：

10.1007/s12181-024-00705-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The current 2023 European Society of Cardiology (ESC) guidelines on acute coronary syndromes (ACS) describe ACS as a disease spectrum and, therefore, for the first time combine the recommendations for the management of patients with ST-elevation myocardial infarction and non-ST-elevation ACS in one set of guidelines. The guidelines have evaluated new treatment concepts and extensive study data and provide, among others, recommendations for an individualized antithrombotic treatment, timing and completeness of myocardial revascularisation, the importance of intracoronary imaging and physiology, myocardial infarction with non-obstructive coronary arteries (MINOCA) as well as special clinical situations. Furthermore, they underline the importance of secondary prevention and the inclusion of patients in treatment decisions. Overall, these very comprehensive guidelines provide clear recommendations on the diagnostics, initial management, invasive and revascularisation strategies as well as on non-pharmacological and pharmacological treatment of patients with ACS in the acute phase, the period of the first 12 months after ACS and especially for long-term treatment.

引用

页码：458 / 469

页数：12

共 31 条

[1] Kommentar zu den Leitlinien der ESC zum VorhofflimmernCommentary on the ESC guidelines on atrial fibrillation
P. Kirchhof
A. Goette
D. Gulba
G. Hindricks
S.H. Hohnloser
Der Kardiologe, 2012, 6 (1): : 12 - 27
[2] Kommentar zu den Leitlinien (2017) der ESC zu peripheren arteriellen ErkrankungenComments on the guidelines (2017) of the ESC on peripheral arterial diseases
C. Espinola-Klein
J. B. Dahm
C. Heiß
R. Zahn
C. Tiefenbacher
Der Kardiologe, 2018, 12 (4): : 241 - 249
[3] Kommentar zu den Leitlinien (2018) der ESC zum Management von kardiovaskulären Erkrankungen in der SchwangerschaftComments on the guidelines (2018) of the ESC on the management of cardiovascular diseases during pregnancy
U. Seeland
J. Bauersachs
U. Kintscher
D. Hilfiker-Kleiner
J. W. Roos-Hesselink
V. Regitz-Zagrosek
Der Kardiologe, 2019, 13 (3): : 138 - 145
[4] Kommentar zu den Leitlinien (2022) der ESC zur Kardio-OnkologieComment on the guidelines (2022) of the ESC on cardio-oncology
Ulf Landmesser
Markus S. Anker
Tienush Rassaf
Lorenz H. Lehmann
Roman Pfister
Christiane Tiefenbacher
Die Kardiologie, 2024, 18 (1) : 5 - 13
[5] Kommentar zu den Leitlinien (2020) der ESC zur Diagnose und Behandlung von VorhofflimmernComments on the 2020 ESC guidelines on diagnosis and management of atrial fibrillation
Gerhard Hindricks
Lars Eckardt
Michael Gramlich
Ellen Hoffmann
Philipp Sommer
Ralph Bosch
Der Kardiologe, 2021, 15 (4): : 354 - 363
[6] Kommentar zu den Leitlinien der European Society of Cardiology (ESC) zur Diagnose und Therapie des akuten Koronarsyndroms ohne ST-Strecken-Hebung (NSTE-ACS)Commentary on the guidelines by the European Society of Cardiology (ESC) on the diagnosis and treatment of acute coronary syndrome without ST elevation (NSTE-ACS)
C.W. Hamm
Der Kardiologe, 2009, 3 (2): : 81 - 100
[7] Kommentar zu den 2016 Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zum Management von VorhofflimmernComments on the 2016 guidelines of the European Society of Cardiology (ESC) for the management of atrial fibrillation
L. Eckardt
T. Deneke
H. C. Diener
G. Hindricks
H. M. Hoffmeister
S. H. Hohnloser
P. Kirchhof
C. Stellbrink
Der Kardiologe, 2017, 11 (3): : 193 - 204
[8] Kommentar zu den 2015‑Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zum Management des akuten Koronarsyndroms ohne ST‑Hebungen (NSTE-ACS)Comments on the 2015 guidelines of the European Society of Cardiology (ESC) for management of non-ST elevation acute coronary syndrome (NSTE-ACS)
J. Mehilli
C. W. Hamm
U. Landmesser
S. Massberg
Der Kardiologe, 2016, 10 (6): : 351 - 358
[9] ESC-Leitlinien 2023 zum Management der EndokarditisWas ist neu?ESC guidelines 2023 on the management of endocarditisWhat is new?
Suzanne de Waha
Steffen Desch
Roland Tilz
Julia Vogler
Madlen Uhlemann
Mateo Marín-Cuartas
Matthias Raschpichler
Michael Borger
Herz, 2024, 49 : 33 - 42
[10] Kommentar zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Behandlung der akuten und chronischen HerzinsuffizienzComments on the guidelines of the European Society of Cardiology (ESC) on the diagnostics and treatment of acute and chronic heart failure
U. Laufs
S. D. Anker
V. Falk
B. Pieske
S. Baldus
C. A. Perings
C. Birner
Der Kardiologe, 2017, 11 (3): : 183 - 192

← 1 2 3 4 →